VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
CROX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
CROXCrocs, Inc.
$118.09$5.9B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCROXCash Flow

Crocs, Inc. (CROX) Cash Flow Statement

23Y historyFree accessUpdated daily

Free cash flow rebounded to $331.0M in 2026Q2 (28.1% margin), with cumulative operating cash flow of $2.0B exceeding net income by $0.9B, but aggressive buybacks ($256.9M in 2026Q2) and seasonal working capital swings drive volatility.

Income StatementBalance SheetCash FlowRatios

CROX Cash Flow Statement

Annual statement

CROX Cash Flow Statement

Crocs, Inc. (CROX) cash flow statement — 23-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03
Cash from Operations790.42M710.43M992.49M930.44M603.14M567.16M266.9M89.96M114.16M98.26M39.75M9.7M-11.65M83.46M128.13M142.38M104.27M61.11M72.86M8.94M12.34M10.5M777K-439K
Operating CF Margin %-17.58%24.19%23.48%16.97%24.52%19.26%7.31%10.49%9.6%3.84%0.89%-0.97%7%11.41%14.22%13.2%9.46%10.1%1.05%3.48%9.67%5.75%-37.68%
Operating CF Growth %3.07%-28.42%6.67%54.27%6.34%112.5%196.7%-21.2%16.18%147.18%309.92%183.24%-113.96%-34.86%-10.01%36.54%70.64%-16.13%715.2%-27.59%17.53%1251.61%276.99%-
Net Income593.42M105.17M950.07M792.57M540.16M725.69M312.86M119.5M50.44M10.24M-16.49M-83.2M-4.93M10.42M131.34M112.79M67.73M-42.08M-185.08M168.23M64.42M16.97M-1.49M-1.2M
Depreciation & Amortization81.56M79.28M69.84M54.3M39.23M31.98M27.62M24.21M29.25M33.13M34.04M35.99M37.41M41.51M36.69M37.26M37.06M36.67M37.45M20.95M8.05M3.33M700K75K
Stock-Based Compensation41.52M36.7M33.05M29.07M31.3M38.12M16.36M14.41M13.11M9.77M10.74M11.24M12.5M11.87M11.32M8.55M7.11M31.43M21.68M21.68M10.26M4.76M00
Deferred Taxes33.08M47.09M-254.45M-410.32M-4.76M-241.28M-325.06M-16.26M959K-3.09M-388K289K829K23.54M-2.98M-819K-5M5.4M-5.43M-14.87M-2.04M-3.09M-191K0
Other Non-Cash Items121.17M589.29M125.55M98.3M88.89M57.18M102.73M59.39M8.45M3.31M-2.15M47.63M24.25M11.07M19.23M-9.9M5.66M24.34M148.87M-51.6M-10.11M1.48M1.79M356K
Working Capital Changes-80.33M-147.1M68.43M366.52M-91.68M-44.53M132.39M-111.3M11.96M44.9M14.01M-2.25M-81.72M-14.94M-67.47M-5.5M-8.28M5.34M55.36M-135.46M-58.23M-12.95M-30K330K
Change in Receivables-13.84M-6.17M42.59M-13.32M-56.77M-35.06M-47.05M-15.02M-24.62M620K2.41M-15.6M-15.29M-17.17M-9.47M-23.28M-13.16M-13.25M-83.95M-79.28M-43.98M-15.2M00
Change in Inventory13.15M-13.84M22.05M86.35M-91.61M-43.06M-13.46M-48.16M-1.99M23.32M20.37M-8.59M-31.25M-5.27M-35.49M-13.33M-27.91M44.83M18.24M-151.59M-54.96M-26.04M-859K-331K
Change in Payables93.35M709K3.95M37.2M41.7M34.87M23.23M6.03M12.95M-2.71M-1.35M23.26M-12.11M-5.74M99K30.31M12.69M-17.39M27.15M27.15M19.96M17.71M00
Cash from Investing-58.01M-51.23M-69.35M-115.67M-2.15B-55.92M-41.76M-36.24M-10.11M-11.54M-19.86M-18.63M-57.99M-69.76M-65.94M-41.66M-42.08M-25.73M-73.44M-62.22M-69.5M-12.17M-6.72M-321K
Capital Expenditures-58.01M-51.23M-69.35M-115.63M-104.19M-55.92M-42.03M-36.58M-11.98M-13.12M-22.19M-18.49M-57.03M-68.83M-60.84M-41.64M-45.1M-27.03M-66.22M-73.9M-29.04M-11.53M-1.55M-321K
CapEx % of Revenue1.43%1.27%1.69%2.92%2.93%2.42%3.03%2.97%1.1%1.28%2.14%1.7%4.76%5.77%5.42%4.16%5.71%4.19%9.18%8.72%8.19%10.62%11.47%27.55%
Acquisitions0000-2.05B6K463K0000-2K00-5.17M-15.32M-12.57M0-7.98M-12.39M-15.4M0-5.17M0
Investments------------------------
Other Investing000-46K-20K-15K-192K340K1.87M1.58M2.34M-139K-966K-930K62K13.58M13.89M2.8M-21.57M1.75M-2.73M000
Cash from Financing-756.5M-714.57M-886.05M-859.64M1.53B-429.64M-198.04M-68.64M-148.8M-65.37M-16.44M-101.26M23.43M-1.16M-16.4M8.92M5.25M-22.19M18.6M43.2M94.55M5.53M6.64M1.01M
Debt Issued (Net)-108.79M-128M-323.25M-665.8M1.59B605M-25M85M119.34M-3.11M-4.04M-5.29M-5.18M10.21M5.46M-1.11M-1.52M-22.79M15.32M6.46M-12.26M8.8M767K400K
Equity Issued (Net)-647.58M-582.32M-560.69M-192.1M-11.48M-1.02B-173.89M-148.72M-246.85M-50M420K-85.93M36.92M-11.28M-21.86M10.42M6.77M-238K3.28M-6.47M96.74M-275K5.88M613K
Dividends Paid0000000-2.98M-21.02M-12M-12M-11.9M-8.23M0000000-171K-275K00
Share Repurchases-647.58M-582.32M-560.69M-192.1M-11.48M-1.02B-173.89M-148.72M-246.85M-50M-324K-85.93M-146.65M-12.79M-25.57M-490K-421K-238K0-25.02M0-275K-150K-12K
Other Financing-141K-4.25M-2.11M-1.74M-53.48M-14.52M854K-1.94M-270K-259K-818K1.86M-75K-100K-225K-398K0832K043.22M10.25M275K00
Net Change in Cash-30.24M-49.77M30.58M-41.79M-22.04M77.65M27.23M-15.48M-49.52M24.56M4.22M-124.17M-49.63M22.8M36.76M112M68.24M25.68M15.33M-6.32M37.87M3.73M728K253K
Free Cash Flow732.41M659.2M923.14M814.82M498.95M511.25M224.87M53.38M102.18M85.15M17.56M-8.79M-68.68M14.64M67.3M100.74M59.17M34.08M6.64M-64.97M-16.7M-1.03M-774K-760K
FCF Margin %18.06%16.31%22.5%20.56%14.04%22.1%16.22%4.34%9.39%8.32%1.69%-0.81%-5.73%1.23%5.99%10.06%7.49%5.28%0.92%-7.67%-4.71%-0.95%-5.72%-65.24%
FCF Growth %-4.75%-28.59%13.29%63.31%-2.41%127.35%321.25%-47.76%20.01%384.89%299.77%87.2%-569.23%-78.25%-33.2%70.25%73.61%412.9%110.23%-288.99%-1523.03%-32.95%-1.84%-
FCF per Share14.6012.1615.4313.158.058.023.280.741.491.180.24-0.12-0.810.170.741.110.680.400.08-0.77-0.10-0.02-0.02-0.01
FCF Conversion (FCF/Net Income)1.23x-8.75x1.04x1.17x1.12x0.78x0.85x0.75x2.26x9.60x-2.41x-0.12x2.37x8.01x0.98x1.26x1.54x-1.45x-0.39x0.05x0.19x0.62x-0.52x0.37x
Interest Paid26.48M099.46M151.62M127.81M10.21M6.66M7.52M462K434K653K917K616K693K619K843K639K1.49M000000
Taxes Paid19.61M0124.96M179.72M130.08M159.68M20.82M16.05M18.63M13.21M12.34M19.92M33.66M20.27M29.39M26.63M11.05M12.39M000000

Key Metrics

Growth RegimeMixed
ProfitabilityStable
Balance SheetMixed
Cash FlowStable
Top Statement Risk

Unresolved net margin divergence

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Cash Conversion Volatility Masks Operating Strength

CROX's operating cash flow to net income ratio swung from -0.58 in 2025Q2 to 1.72 in 2026Q2, reflecting non-cash charges and working capital swings. According to the latest quarterly data, the 2025Q2 net loss of $492.3M contrasts with $285.8M operating cash flow.

The negative OCF/NI ratios in 2025Q1 and 2025Q2 are driven by large working capital outflows, not operational deterioration, as operating cash flow remained positive in 2025Q2. The 2026Q2 ratio of 1.72 indicates high earnings quality, with cash conversion exceeding net income due to non-cash add-backs and favorable working capital. Investors should monitor the recurring working capital swings, which appear seasonal and may distort quarterly comparisons.

Free Cash Flow Rebounding After Seasonal Dip

FCF margin recovered to 28.1% in 2026Q2 from -7.7% in 2026Q1, with FCF of $331.0M versus $204.9M net income. As reported in the cash flow statement, the trailing twelve-month FCF margin stands at approximately 18%, supported by strong operating cash generation.

The first-quarter negative FCF is a recurring seasonal pattern, as working capital builds ahead of spring/summer demand. The 2026Q2 FCF of $331.0M is the highest in the ten-quarter period, suggesting improving operational efficiency and brand momentum. However, the 2025Q2 net loss of $492.3M did not impact cash flow, indicating the loss was non-cash, which supports the quality of the underlying cash generation.

Low Capital Intensity Preserves Cash Flow

CapEx averaged just 1.5% of revenue over the past ten quarters, with 2026Q2 at 1.8%, reflecting the asset-light injection-molding model. Based on the cash flow data, CapEx of $20.7M in 2026Q2 is minimal relative to $1.18B revenue, enabling high FCF conversion.

The low capital intensity is a structural advantage, as the single-mold production process requires limited ongoing investment. Maintenance capex appears sufficient to sustain operations, with D&A of $20.0M roughly matching CapEx, suggesting no significant underinvestment. This allows CROX to allocate substantial cash to buybacks and debt reduction, as evidenced by $256.9M in buybacks in 2026Q2.

Seasonal Working Capital Swings Drive Cash Flow Volatility

Working capital changes swung from -$292.1M in 2025Q1 to +$167.7M in 2024Q4, with 2026Q2 showing a $81.0M positive contribution. According to the cash flow statement, these swings are the primary driver of quarterly OCF volatility, not operational deterioration.

The negative working capital changes in Q1 quarters reflect inventory builds ahead of peak selling season, while Q4 and Q2 show positive contributions from collections and payables management. The 2026Q2 positive $81.0M suggests efficient inventory and receivables management, supporting the strong cash conversion. Investors should expect continued seasonal volatility, but the underlying trend appears stable with no evidence of structural working capital deterioration.

Aggressive Buybacks Despite Net Loss Quarter

CROX repurchased $256.9M in 2026Q2, the highest in the period, even as net income was $204.9M. As reported in the cash flow statement, buybacks totaled over $1.4B in the last ten quarters, funded by robust operating cash flow, with no dividends paid.

The capital deployment strategy prioritizes share repurchases, which appear accretive given the low valuation relative to peers. The 2025Q2 buyback of $133.3M despite a net loss indicates management's confidence in cash generation and long-term value. However, the lack of dividends and heavy buyback reliance may signal limited alternative investment opportunities, and the elevated leverage (D/E of 1.25) warrants monitoring.

Cumulative Cash Generation Exceeds Net Income

Over the ten quarters, cumulative operating cash flow of $2.0B exceeds cumulative net income of $1.1B, a gap of $0.9B. Based on the cash flow data, this divergence highlights the impact of non-cash charges, particularly the 2025Q2 impairment, and suggests robust cash earnings power.

The cumulative OCF/NI ratio of approximately 1.8 indicates that reported net income understates cash generation, largely due to non-cash charges like impairments and D&A. This supports the view that the negative net margin in 2025Q2 was a one-time event, not a recurring operational issue. However, the persistent gap between operating margin and net margin in the TTM period suggests ongoing non-operating costs that investors should continue to scrutinize.

What the Cash Flow Statement Obscures

Despite strong operating cash flow, the persistent gap between operating margin (22.0%) and net margin (-2.0%) suggests non-cash charges or interest that may not be fully captured in cash flow. As reported in the cash flow data, SBC of $14.2M in 2026Q2 is modest, but the unresolved net margin divergence warrants forensic review.

The cash flow statement shows robust OCF, but the TTM net margin of -2.0% versus operating margin of 22.0% implies significant non-operating drags, likely interest or impairments, that are not visible in operating cash flow. The elevated Debt/Equity of 1.25, if accurate, suggests leverage that could amplify downside risk, though the cash flow data does not directly reveal the nature of these costs. Investors should monitor whether these non-operating items are recurring, as they could erode the apparent cash generation strength.

CROX — Frequently Asked Questions

Quick answers to the most common questions about buying CROX stock.

How much cash does Crocs, Inc. (CROX) generate from operations?

Crocs, Inc. (CROX) generated $710.4M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Crocs, Inc.'s free cash flow?

Crocs, Inc. (CROX) generated $659.2M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Crocs, Inc.'s capital expenditure (CapEx)?

Crocs, Inc. (CROX) spent $51.2M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Crocs, Inc. distribute cash to shareholders?

In 2025, Crocs, Inc. (CROX) spent $582.3M on share repurchases. This shows the company's commitment to returning capital to its equity investors.